37^th World Pharmacology and Therapeutics Forum October 25-26, 2021 Rome, Italy

Session 1: Pharmacology

Pharmacology which deals with the medication action. A medication may be extensively characterized as any synthetic, artificial, characteristic, or endogenous  atom which applies organic chemistry and in addition physiological impact on the cell, tissue, organ, or living being. Significantly it's the investigation of the associations that happen between a living body and chemicals that influence typical or abnormal organic chemistry capability and substances which are having therapeutic properties, they are concluded as pharmaceuticals.

Session 2: Toxicology

Toxicology is the scientific study of adverse effects that occur in living organisms because of chemicals. It involves perceptive and reporting symptoms, mechanisms, detection and treatment of poisonous substances, specially respect to the poisoning of humans. It includes environmental agents and chemical compounds found in nature, likewise as pharmaceutical compounds that are synthesized for medical use by humans.

Session 3: Pharmacology and Drug Design

Pharmacology is the branch of science worried with the investigation of medication action, where a medication can be extensively characterized as any man-made, characteristic, or endogenous atom which applies organic chemistry and physiological impact on the cell, tissue, organ, or living being. Drug design study explains the design of chemical molecules that are complementary in shape and charge to the endogenous target with which they interact and therefore will bind to it.

Session 4: Clinical and Medical Toxicology

Clinical toxicology is the branch of science which deals with the removing of the poisonous substances or harmful chemicals from the body of any organism. Clinical toxicologists are the people who are expertized in the field of detoxification. Medical toxicology is a part of the toxicology and deals with the removal of the harmful toxins from the body. The poisoning may be intentional or unintentional but the adverse effects may lead to the lethal damage to the organism.

Session 5: Clinical Pharmacology and Receptor Therapy     

Clinical pharmacology has been practiced for hundreds of years through perceptive results of herbal remedies and early medication on humans. Since long scientific advances allowed scientists to come back with the study of physiological effects with biological effects. Receptor theory for drug effects and its discovery with clinical pharmacological medicine has extended to be a multidisciplinary field and has contributed to the findings of drug interaction, therapeutic effectiveness and safety. 

Session 6: Pharmacotoxicology

The pharmacotoxicology mainly deals with prevention and control of pharmaceutically induced adverse health effects. The pharmacotoxicology is separated into two categories that is: pharmacokinetics and pharmacodynamics .The pharmaceutical products show toxicity during conditions like drug-drug interactions, bio activation of drugs and due to immune system response to the pharmaceutical product. Sometimes the drugs are toxic due to interaction with alternative targets. 

Session 7:  Clinical Therapeutics

In broad sense, therapeutics means serving and caring for the patients in a complete manner, inhibiting disease as well as treating particular problems. Exercise, diet, and mental factors are therefore essential to the prevention as well as the management of disease processes. Particular measures that are employed to treat actual symptoms includes, the use of medicine to get rid of pain or treat infection, surgery to remove unhealthy tissue or replace poorly functioning or non-functioning organs with fully operating ones and counselling to relieve emotional distress.

Session 8: Cognitive Behaviour Therapy and Holistic Therapy  

Cognitivetherapy defines as a time-sensitive, organised, current oriented psychotherapy focussed towards solving present problems and teaching clients skills to alter dysfunctional thinking and behaviour. It focuses on present thinking, behaviour, and communication rather than on past experiences and is oriented towards problem solving. Holistic Energy psychotherapy is the application and repetition of vibrant energy-sensitive healing modalities. Holistic Energy psychotherapy is based upon the theory that traumatic memories and the negative beliefs, emotions and behaviours that often result from them are experienced as energy blocks in the human energy field. By introducing techniques and tools into therapy that help to restore balance to our energy field, many psychological and emotional problems often resolve rapidly and fully, never to return

Pharma Forum 2020

35^th World Pharmacology and Toxicology Forum was hosted by the Conference Series LLC LTD. It was actually planned at Tokyo, Japan during September 21-22, 2020 with the theme “Novel Therapeutic Approaches in Pharmacology” but we ended it as a webinar due to the pandemic situation and it was organized successfully. The Webinar marked its start by an opening ceremony which included introduction by the Honorable Guest and the Members of Keynote Forum: Ralph Bruckner (Germany), Vuong Trieu (USA), Alexander Solodovnikov (Russia), Galina Mal (Russia), Kinjal Solanki (India), Kanathip Singsai (Thailand), Hans Verhagen (Italy), Sara Carpi (Italy), Del Potter (USA), Akachukwu Ibezim (Nigeria). Scientific sessions discussed during webinar are about Pharmacology, Toxicology, Therapeutics, Drug Design and Pharmacogenomics

Nano Pharmaceuticals 2019

2^nd International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine held during March 20-21, 2019 in New York, USA with the theme “Navigating the Future of Nanomedicine & Nanotechnology”. It is our Pleasure to show our appreciation towards our Chairs/Co-Chairs for the Sessions, namely Istvan Toth, The University of Queensland (Australia), Xudong Huang, Harvard Medical School (USA), Toyoko Imae, National Taiwan University of Science and Technology (Taiwan), Jordi Arbiol, Catalan Institute of Nanoscience and Nanotechnology (Spain), Vladimir P. Torchilin, Northeastern University (USA), Arend L. Mapanawang, Stikes Halmahera (Indonesia), Hendry Izaac Elim, Pattimura University (Indonesia). Scientific sessions discussed by the eminent speakers are about Nanoparticles, Nanomedicine, Nanobiotechnology, Nanorobotics, Pharmaceutical Formulations and Nano Drug Systems

Pharmaceutica 2018

The 16^th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, was held during March 19-21, 2018 at Best Western Premier, Airport hotel Fontane Berlin, Germany based on the theme "Emerging Drug Delivery Technologies". The conference was initiated with the Honorable presence of the Keynote forum. The list includes: Vladimir Torchilin, Northeastern University (USA), Wei-Chiang Shen, University of Southern California (USA), Hyungil Jung, Yonsei University (South Korea), Kostas D Demadis, University of Crete (Greece). Scientific sessions discussed during the conference are Pharmaceutical Chemistry, Pharmaceutical Analysis, Bio-Pharmaceutics, Pharmacovigilance, Drug Safety, and Novel Drug Delivery Systems

Pharmacology 2017

Conference Series hosted 9^th World Congress on Pharmacology scheduled during September 04-06, 2017 at Hotel Novotel Marne la Vallée Noisy le Grand, Paris, France with the theme “Grooming the Pharmacological Boundaries for Drug Discovery and Development". We received active participation from various scientists, researchers, students and leaders from the field of Pharmacology who made this event successful. The conference was initiated with a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The list includes: Kjell Fuxe (Sweden), Zhi-Yi Zhang (USA), María Esperanza Avella Vargas (Columbia), Layla E Borham (Saudi Arabia), Sanaa S Botros (Egypt). Scientific sessions discussed by the eminent speakers are Drug Discovery, Pharmacogenetics, Pharmacoepidemiology, Pharmaco-Economics, and Nursing Pharmacology

Clinical Pharmacy 2016

The 4^th International Pharma & Clinical Pharmacy Congress scheduled during November 07-09, 2016 in Las Vegas, USA with the theme “Development, Innovative Techniques and Advanced Practices in Clinical Pharmacy” was a great success where eminent speakers from various reputed institutions and organizations with their presence addressed the gathering: Roseane Maria Maia Santos, South University School of Pharmacy (USA), Monika I Konaklieva, American University (USA), Haydar Al-Tukmagi, Baghdad College of Pharmacy (Iraq), Jingwen Wang, Xijing Hospital (China), Sabah H. Akrawi, King Faisal University (Saudi Arabia). Scientific sessions discussed during the conference by speakers are about Clinical Pharmacology, Psychopharmacology, Clinical Drug Trails, Pharma Research, and Radiopharmaceuticals

With the grand success of Pharma Conferences, we are pleased to announce the “37^th World Pharmacology and Therapeutics Forum” (Pharma Forum 2021) to be held during October 25-26, 2021 in Rome, Italy.

This Pharma Forum 2021 will give you exemplary experience and great insights in the field of research. The global pharmaceuticals market was worth $934.8 billion in 2017 and will reach $1170 billion in 2021, growing at 5.8%, according to a recent pharma market research report by The Business Research Company.

The factors that affect the pharmaceutical market size include disease prevalence, drug affordability, consumer attitudes, government policies and some supply-side factors:

• Disease prevalence is related to population size, age, genetic inheritance and behavior (infectious disease incidence is lower where sanitation practices are better; sedentary lifestyles also encourage chronic disease).
• Affordability is related to income but also to drug prices.
• Consumer attitudes include willingness to use alternative therapies or distrust of taking drugs.
• Government (and insurance company) policies affect reimbursement and who the payer is. Other government policies determine regulation, which can be a significant barrier to the launch of new treatments.
• A major supply-side factor is availability of an appropriate treatment, which may be a matter of quantity, as in an epidemic, or of drug discovery and development.

Italy applies health-related restriction measures to incoming travellers, which may vary depending on their country of origin. EU citizens and residents can enter Italy without any quarantine obligation, provided that:

1. They fill in the Passenger Locator Form before entering Italy
2. They can get the EU Digital COVID Certificate from their national health authorities. An EU Digital COVID Certificate is a digital proof that a person has either:

• been vaccinated against COVID-19 at least 14 days beforehand
• received a negative test result
• recovered from COVID-19

Travellers from the Schengen area, Israel, Canada, Japan and the United States can enter Italy without any quarantine obligation, provided that:

1. They fill in the Passenger Locator Form before entering Italy
2. They present on arrival a COVID-19 Green Pass issued by the Health Authorities their home country, certifying:

• complete vaccination against COVID-19 performed at least 14 days beforehand
• recovery from COVID-19 and the termination of medical isolation
• negative result for a rapid molecular or antigenic test performed in the 48 hours prior to entry into Italy